ClinicalTrials.gg
CompletedNCT07698301Updated Jul 13, 2026

Mini TightRope Suspensionplasty Versus Ligament Reconstruction and Tendon Interposition for Thumb Carpometacarpal Osteoarthritis

An interventional study of Mini tightrope suspensionplasty and Ligament Reconstruction and Tendon Interposition (LRTI) in Carpometacarpal (CMC) Joint Arthritis, sponsored by Theodoros Mylonas. Completed at 1 site in Greece. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-13.

Sponsored by Theodoros Mylonas · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 6 years 6 months after the study started (first participant enrolled Jan 2020, registered Jul 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Thumb carpometacarpal osteoarthritis is a common cause of pain, weakness and functional disability. Trapeziectomy with ligament reconstruction and tendon interposition (LRTI) is considered a standard surgical procedure, whereas Mini TightRope suspensionplasty has been introduced to facilitate earlier mobilization while maintaining first metacarpal stability.

This prospective randomized single-center clinical trial compares Mini TightRope suspensionplasty with LRTI in patients with symptomatic Eaton-Littler stage II-IV thumb carpometacarpal osteoarthritis. Fifty patients were randomized in a 1:1 ratio to undergo either Mini TightRope suspensionplasty or LRTI. Clinical and radiographic outcomes were evaluated preoperatively and at 3 months, 6 months, 1 year and 2 years postoperatively.

The primary outcome was the Quick Disabilities of the Arm, Shoulder and Hand (qDASH) score at 2 years. Secondary outcomes included pain, thumb opposition, grip strength, pinch strength, operative time, radiographic preservation of metacarpal height and complications.

02

Conditions studied

  • Carpometacarpal (CMC) Joint Arthritis

Keywords

  • CMC arthritis
  • mini tightrope
  • tendon interposition
  • trapeziectomy
03

In context

Lead sponsor

This is the only study on the registry with Theodoros Mylonas as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Symptomatic thumb carpometacarpal osteoarthritis
  • Eaton-Littler stage II-IV
  • Failure of at least six months of conservative treatment
  • Ability to provide
  • Ability to comply with follow-up

Exclusion criteria

Exclusion Criteria

  • Inflammatory arthritis
  • Previous thumb surgery
  • Concomitant carpal pathology
  • Incomplete radiographs
  • Inability to comply with rehabilitation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Mini TightRope Suspensionplasty

    Complete trapeziectomy followed by suspension of the first metacarpal using the Arthrex Mini TightRope suture-button system.

    Procedure: Mini tightrope suspensionplasty

  • Active comparator
    Ligament Reconstruction and Tendon Interposition (LRTI)

    Complete trapeziectomy with ligament reconstruction using the flexor carpi radialis tendon and tendon interposition.

    Procedure: Ligament Reconstruction and Tendon Interposition (LRTI)

Interventions

  • ProcedureMini tightrope suspensionplasty

    Complete trapeziectomy followed by suspension of the first metacarpal using the Arthrex Mini TightRope suture-button system

  • ProcedureLigament Reconstruction and Tendon Interposition (LRTI)

    Complete trapeziectomy with ligament reconstruction using the flexor carpi radialis tendon and tendon interposition.

06

What researchers measure

Primary outcomes

  1. quick DASH score

    Quick Disabilities of the Arm, Shoulder and Hand score measured preoperatively and during follow-up, with the primary endpoint at two years.

    Time frame: 2 years

Secondary outcomes

  1. VAS score

    Visual Analog Scale pain score

    Time frame: 2 years

  2. Kapandji score

    Kapandji thumb opposition score

    Time frame: 2 years

  3. Grip strength

    Grip strength using a dynamometer

    Time frame: 2 years

  4. Trapeziometacarpal Index

    the ratio between the distance from the base of the first metacarpal to the distal surface of the scaphoid and the total length of the first metacarpal

    Time frame: 2 years

07

Study locations

1 site
  • University Hospital of Larissa, Thessaly, Greece
    Larissa, Thessaly 41500, Greece
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2020 to primary completion in Dec 2025, 71 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 7, 2026
First posted
Jul 13, 2026
StartActual
Jan 1, 2020
Primary completionActual
Dec 1, 2025
CompletionActual
Dec 1, 2025
Last update
Jul 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07698301
Lead sponsor
Theodoros Mylonas
Responsible party
Theodoros Mylonas (Resident of Orthopaedics, University of Thessaly) — Sponsor-investigator
First posted
Jul 13, 2026
Start date
Jan 1, 2020
Primary completion
Dec 1, 2025
Completion
Dec 1, 2025
Last update
Jul 13, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion